Literature DB >> 17006565

Managing ventricular tachyarrhythmias in the developing world: insights from recent ICD trials.

K K Talwar, N Naik.   

Abstract

Entities:  

Year:  2001        PMID: 17006565      PMCID: PMC1569892     

Source DB:  PubMed          Journal:  Indian Pacing Electrophysiol J        ISSN: 0972-6292


× No keyword cloud information.
  18 in total

1.  Do baseline characteristics accurately discriminate between patients likely versus unlikely to benefit from implantable defibrillator therapy? Evaluation of the Canadian implantable defibrillator study implantable cardioverter defibrillatory efficacy score in the antiarrhythmics versus implantable defibrillators trial.

Authors:  D V Exner; R S Sheldon; S L Pinski; J Kron; A Hallstrom
Journal:  Am Heart J       Date:  2001-01       Impact factor: 4.749

Review 2.  Implantable cardioverter defibrillator therapy: the sickest patients benefit the most.

Authors:  A J Moss
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

3.  Implantable cardioverter-defibrillator: A Volkswagen or a Rolls Royce: how much will we pay to save a life?

Authors:  D P Zipes
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

4.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH).

Authors:  K H Kuck; R Cappato; J Siebels; R Rüppel
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

5.  Cost-effectiveness of the implantable cardioverter-defibrillator: results from the Canadian Implantable Defibrillator Study (CIDS).

Authors:  B J O'Brien; S J Connolly; R Goeree; G Blackhouse; A Willan; R Yee; R S Roberts; M Gent
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

6.  "Stable" ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators (AVID) registry.

Authors:  M H Raitt; E G Renfroe; A E Epstein; J H McAnulty; P Mounsey; J S Steinberg; S E Lancaster; R L Jadonath; A P Hallstrom
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

7.  What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?

Authors:  B H Sarter; J K Finkle; R E Gerszten; A E Buxton
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

8.  Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study.

Authors:  R Sheldon; S Connolly; A Krahn; R Roberts; M Gent; M Gardner
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

9.  Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest.

Authors:  D Böcker; M Block; F Isbruch; C Fastenrath; M Castrucci; D Hammel; H H Scheld; M Borggrefe; G Breithardt
Journal:  Br Heart J       Date:  1995-02

Review 10.  Sudden cardiac death: epidemiology, transient risk, and intervention assessment.

Authors:  R J Myerburg; K M Kessler; A Castellanos
Journal:  Ann Intern Med       Date:  1993-12-15       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.